Fuminori Masugi

650 total citations
38 papers, 540 citations indexed

About

Fuminori Masugi is a scholar working on Molecular Biology, Biochemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Fuminori Masugi has authored 38 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Biochemistry and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Fuminori Masugi's work include Enzyme Structure and Function (7 papers), Amino Acid Enzymes and Metabolism (5 papers) and Hormonal Regulation and Hypertension (5 papers). Fuminori Masugi is often cited by papers focused on Enzyme Structure and Function (7 papers), Amino Acid Enzymes and Metabolism (5 papers) and Hormonal Regulation and Hypertension (5 papers). Fuminori Masugi collaborates with scholars based in Japan and Spain. Fuminori Masugi's co-authors include Toshio Ogihara, Y Kumahara, Atsuhiro Otsuka, Tohru Ogihara, Kazushige Sakaguchi, Yoshitake Terano, Masahiro Nagano, Saburo Fukui, Shu Saeki and Takemi Hasegawa and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Hypertension and Archives of Biochemistry and Biophysics.

In The Last Decade

Fuminori Masugi

38 papers receiving 512 citations

Peers

Countries citing papers authored by Fuminori Masugi

Since Specialization

Citations

This map shows the geographic impact of Fuminori Masugi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuminori Masugi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuminori Masugi more than expected).

Fields of papers citing papers by Fuminori Masugi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuminori Masugi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuminori Masugi. The network helps show where Fuminori Masugi may publish in the future.

Co-authorship network of co-authors of Fuminori Masugi

This figure shows the co-authorship network connecting the top 25 collaborators of Fuminori Masugi. A scholar is included among the top collaborators of Fuminori Masugi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuminori Masugi. Fuminori Masugi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dietary salt, blood pressure and circulating levels of 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in patients with essential hypertension. 1992 ·PubMed ·Fuminori Masugi, Kazushige Sakaguchi, Shu Saeki, Masakazu Imaoka, Toshio Ogihara	2
2	PRODUCTION AND CHARACTERIZATION OF ANTIBODIES TO OUABAIN 1991 ·Japanese Journal of Medical Science and Biology ·Yoshitake Terano, (unknown), Fuminori Masugi	12
3	PRODUCTION OF ANTI-PLATELET-ACTIVATING FACTOR ANTIBODIES BY THE USE OF COLLOIDAL GOLD AS CARRIER 1991 ·Japanese Journal of Medical Science and Biology ·(unknown), Fuminori Masugi	11
4	Studies on the role of platelet‐activating factor in blood pressure regulation 1991 ·Lipids ·Katsuhiko Sakaguchi, Shigeto Morimoto, Fuminori Masugi, (unknown), Toshio Ogihara, Kouji Yamada, Isao Yamatsu	8
5	Case Report: Autoimmune Neutropenia with Anti-neutrophil Autoantibody Associated with Sjögren’s Syndrome 1990 ·The American Journal of the Medical Sciences ·Eiji Yamato, (unknown), Fuminori Masugi, Mitsuaki Nakamaru, Yasuhiro Tahara, Toshio Ogihara, Yoshiyuki Kurata	10
6	A Case of Recessive Dystrophic Epidermolysis Bullosa Associated with Dwarfism with Special Reference to Pathophysiological Role of Growth Hormone 1990 ·Folia Endocrinologica Japonica ·Fumiaki Nakamura, Hiromi Rakugi, Keisuke Fukuo, Mitsuaki Nakamaru, Fuminori Masugi, Toshio Onishi, Toshio Ogihara, Koji Hashimoto, Takehito Kozuka, Kunihiko Yoshikawa	1
7	Graves' Disease with Markedly Elevated Serum Immunoglobulin E 1989 ·Folia Endocrinologica Japonica ·(unknown), Hiromi Rakugi, Mitsuaki Nakamaru, Fuminori Masugi, Toshio Ogihara, Shin‐ichiro Takai	2
8	Partial purification and properties of a plasma ouabain-like inhibitor of Na+,K+-ATPase in patients with essential hypertension 1988 ·Journal of Hypertension ·Fuminori Masugi, Toshio Ogihara, Katsuhiko Sakaguchi, (unknown), (unknown), (unknown), (unknown), Y Kumahara	12
9	Endogenous platelet-activating factor and anti-platelet-activating factor in patients with renovascular hypertension 1988 ·Life Sciences ·Fuminori Masugi, Toshio Ogihara, (unknown), Katsuhiko Sakaguchi, Y Kumahara, Kiyoshi Satouchi, Makoto Oda, Kunihiko Saito, (unknown)	12
10	Normalization of high plasma level of ouabain-like immunoreactivity in primary aldosteronism after removal of adenoma. 1988 ·PubMed ·Fuminori Masugi, Tohru Ogihara, Takemi Hasegawa, Kazushige Sakaguchi, (unknown)	34
11	Ouabain-Like and Non-Ouabain-Like Factors in Plasma of Patients with Essential Hypertension 1987 ·Clinical and Experimental Hypertension Part A Theory and Practice ·Fuminori Masugi, Toshio Ogihara, (unknown), Y Kumahara	26
12	Sensitive assay and kinetic property of urinary inhibitor of Na+, K+-ATPase in sodium-loaded patients with essential hypertension. 1985 ·Japanese Circulation Journal ·Fuminori Masugi, Toshio Ogihara, (unknown), Nobuyuki Imai, Masahiro Nagano, Yoshikatsu Tabuchi, Y Kumahara	2
13	Effect of 1-alkyl-2-acetyl--glycero-3-phosphorylcholine inhibitor on the reduction of one-kidney, one clip hypertension after unclipping in the rat 1984 ·Life Sciences ·Fuminori Masugi, Toshio Ogihara, Atsuhiro Otsuka, (unknown), Y Kumahara	26
14	The role of antihypertensive polar renomedullary lipid in the pathogenesis of hypertension. 1984 ·Japanese Circulation Journal ·Fuminori Masugi, Toshio Ogihara, Atsuhiro Otsuka, (unknown), Y Kumahara	1
15	α-Adrenergic Blocking Action of 1-O-Hexadecyl-2-0-Acetyl-sn-Glycero-3-Phosphocholine in Rats 1983 ·Clinical and Experimental Hypertension Part A Theory and Practice ·Atsuhiro Otsuka, Fuminori Masugi, Toshio Ogihara, (unknown), (unknown), Y Kumahara	7
16	Effect of d,l-.ALPHA.-tocopheryl esters on vitamin E-deficient rats. 1978 ·Journal of Nutritional Science and Vitaminology ·Tetsuya Nakamura, (unknown), Fuminori Masugi	2
17	Interaction of tyrosine phenol-lyase with pyridoxal phosphate N-oxide and 2′-hydroxy pyridoxal phosphate 1973 ·Biochimica et Biophysica Acta (BBA) - Enzymology ·(unknown), Hideaki Yamada, Fuminori Masugi, Saburo Fukui	2
18	TRANSFER OF PYRIDOXAL 5'-PHOSPHATE FROM ALBUMIN-PYRIDOXAL 5'-PHOSPHATE COMPLEX TO APO-ASPARTATE AMINOTRANSFERASE 1973 ·Journal of Nutritional Science and Vitaminology ·Fuminori Masugi, (unknown), Shoichi Shimizu, Saburo Fukui	9
19	INHIBITION OF ACTIVITIES OF ASPARTATE AMINO-TRANSFERASE AND TRYPTOPHANASE BY EXCESS BINDING OF PYRIDOXAL 5'-PHOSPHATE 1973 ·Journal of Nutritional Science and Vitaminology ·Fuminori Masugi, (unknown), Shoichi Shimizu, Saburo Fukui	3
20	PYRIDOXAL PHOSPHATE N-OXIDE. ANALYSES OF COENZYMATIC ACTIVITIES FOR TRYPTOPHANASE AND ASPARTATE AMINOTRANSFERASE BY USE OF STOPPED FLOW METHOD 1973 ·Journal of Nutritional Science and Vitaminology ·Fuminori Masugi, Toshihiko Maeda, (unknown), Shoichi Shimizu, Saburo Fukui	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact